⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vinylsulfonic Acid SCHEMBL9630052 | 0.87 | OR51E2 (0.54) | — | |
| 2-Pyrrolidone SCHEMBL27652961 | 0.86 | — | — | |
| 2-Pyrrolidone SCHEMBL2143364 | 0.86 | — | — | |
| 2-Pyrrolidone SCHEMBL27444417 | 0.86 | — | — | |
| 2-Pyrrolidone SCHEMBL27463398 | 0.86 | — | — | |
| 2-Pyrrolidone SCHEMBL6535468 | 0.86 | — | — | |
| 2-Pyrrolidone SCHEMBL27691599 | 0.86 | — | — | |
| 2-Pyrrolidone SCHEMBL622496 | 0.86 | — | — | |
| 2-Pyrrolidone SCHEMBL2702899 | 0.86 | — | — | |
| 2-Pyrrolidone SCHEMBL27490141 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151919-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | IFM DUE, INC. (US) | 2024-07-18 | — | — | WO | disclosed |
| EP-4384503-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | IFM Due, Inc. (US) | 2024-06-19 | — | — | EP | disclosed |
| CN-118119595-A | Compounds and compositions for the treatment of diseases associated with STING activity | 艾福姆德尤股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| WO-2024064358-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | IFM DUE, INC. (US) | 2024-03-28 | — | — | WO | disclosed |
| US-20240101556-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2024-03-28 | — | — | US | disclosed |
| US-20240083879-A1 | OXALAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2024-03-14 | — | — | US | disclosed |
| US-20240083895-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2024-03-14 | — | — | US | disclosed |
| US-20240076285-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2024-03-07 | — | — | US | disclosed |
| CN-117597327-A | Pharmaceutical preparation | 第一波动生物制药股份有限公司 | 2024-02-23 | — | — | CN | disclosed |
| US-20240051970-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2024-02-15 | — | — | US | disclosed |
| WO-2020236586-A1 | N-HETARYL-SQUARAMIDE COMPOUNDS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | IFM DUE, INC. (US) | 2020-11-26 | — | — | WO | disclosed |
| WO-2020150417-A2 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | IFM DUE, INC. (US) | 2020-07-23 | — | — | WO | disclosed |
| WO-2020150439-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | IFM DUE, INC. (US) | 2020-07-23 | — | — | WO | disclosed |
| US-20200172534-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2020-06-04 | — | — | US | disclosed |
| US-20190083642-A1 | TREATMENTS UTILIZING A POLYMER-PROTEIN CONJUGATE | REGENTIS BIOMATERIALS LTD. (IL) | 2019-03-21 | — | — | US | disclosed |
| EP-3436076-A1 | TREATMENTS UTILIZING A POLYMER-PROTEIN CONJUGATE | Regentis Biomaterials Ltd. (IL) | 2019-02-06 | — | — | EP | disclosed |
| WO-2017168428-A9 | TREATMENTS UTILIZING A POLYMER-PROTEIN CONJUGATE | REGENTIS BIOMATERIALS LTD. (IL) | 2017-11-30 | — | — | WO | disclosed |
| WO-2017168428-A1 | TREATMENTS UTILIZING A POLYMER-PROTEIN CONJUGATE | REGENTIS BIOMATERIALS LTD. (IL) | 2017-10-05 | — | — | WO | disclosed |
| US-7738752-B2 | Optical waveguide system | KABUSHIKI KAISHA TOSHIBA (JP) | 2010-06-15 | — | — | US | disclosed |
| US-20100021104-A1 | OPTICAL WAVEGUIDE SYSTEM | KABUSHIKI KAISHA TOSHIBA (JP) | 2010-01-28 | — | — | US | disclosed |